Evonik Industries AG
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Christian Kullmann
- Full Time Employees
- 31,585
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- Rellinghauser Strasse 1-11 Essen Germany 45128
- IPO Date
- Aug 12, 2013
- Website
- corporate.evonik.com
- Similar Companies
- Business
- Evonik Industries AG is a leading specialty chemicals company headquartered in Essen, Germany, founded in 2007. The company manufactures and supplies a broad range of specialty chemical products organized into two main segments: Custom Solutions and Advanced Technologies. Its core product portfolio includes specialty additives; nutrition and care products such as animal nutrition solutions, pharmaceutical and medical ingredients, and cosmetic ingredients; smart materials including high-performance polymers, silica, and catalysts; and performance materials such as intermediates for plastics, rubber, and mobility industries. Additionally, Evonik offers technology and infrastructure services encompassing process technology, logistics, plant maintenance, and engineering solutions. Evonik operates globally with major production facilities in Germany, Belgium, the United States, China, and Singapore, serving markets in the Americas, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company targets industries including agriculture, automotive, aerospace, construction, consumer goods, healthcare, and pharmaceuticals. Special emphasis is placed on sustainable innovation, with a strategic goal to increase NextGen Solutions—products with significant sustainability benefits—to more than 50% of sales by 2030. In the last two years, Evonik has undergone significant restructuring to strengthen growth and profitability. It realigned its Coating & Adhesive Resins and Health Care business lines to focus investments on core areas while divesting or discontinuing non-core businesses generating approximately €350 million in sales. In late 2024, Evonik reorganized its operations into two segments—Custom Solutions and Advanced Technologies—reducing complexity, streamlining management layers, and enabling more agile responses to market demands. The company has also expanded its polyamides production in Shanghai, China, doubling capacity for long-chain polyamides, reaffirming its leadership in high-performance polymers. Evonik announced a €700 million investment plan in Next Generation Technologies to boost efficiency and reduce carbon emissions in production, further demonstrating its commitment to sustainable growth. Overall, Evonik Industries AG is positioned as a global specialty chemical leader with a diversified product base, expanding innovation in sustainable solutions, and ongoing strategic restructuring to capture growth opportunities across multiple industries and regions.
Evonik Industries AG (EVKIY) Q1 2026 Earnings Call Transcript
Evonik Industries (OTCMKTS:EVKIF) Shares Up 7.5% – What’s Next?
Evonik Industries AG (EVKIY) Q4 2025 Earnings Call Transcript
Evonik Industries AG (EVKIY) Q3 2025 Earnings Call Transcript
Evonik: Revised Outlook Necessitates A Q3 2025 Update
Look Beyond The Volatility In Evonik Industries
Evonik Industries AG (EVKIF) Q2 2025 Earnings Call Transcript
Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript
Evonik: Decent Rate Of Return, Upside Confirmed
Evonik Industries AG (EVKIF) Q4 2024 Earnings Call Transcript
Evonik: A Good Company, Upside Less Clear Than Before
Evonik Industries AG (EVKIF) Q3 2024 Earnings Call Transcript
AI-Driven Market Transformation, Emission Control Catalysts Market to Grow by USD 4.01 Billion (2024-2028) Boosted by Global Automotive Sector - Technavio Report
Squalene Market to Grow by USD 62.9 Million from 2024-2028, Driven by Rising Adoption of UVA/UVB Filters in Sunscreens, Report Powered by AI - Technavio
Evonik - I Continue To Be Long Here
Evonik: Another Exit In A Low Margin Division
Evonik says recovery unlikely in 2024, plans 2,000 job cuts
Evonik: The Reversal Could Be Significant, 'Buy'
Evonik Industries AG (EVKIF) Q3 2023 Earnings Conference Call Transcript
Evonik Industries AG (EVKIF) Q2 2023 Earnings Call Transcript